Zydus and Synthon inks licensing and supply agreement for Palbociclib Tablets for US market
Synthon will be responsible for obtaining US regulatory approval for Palbociclib Tablets
Synthon will be responsible for obtaining US regulatory approval for Palbociclib Tablets
The PAI was conducted for two drug product applications (ANDAs) filed from this facility
Pimavanserin is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson disease psychosis
The bold, dynamic, and new logo unveiled in this process captures the essence of the 'Better Together' theme
The certification underscores Venus Remedies Limited's adherence to stringent quality control measures
The company has posted net profit of Rs.33.57 crores for the 9 Months period ended December 31, 2023
Collaboration streamlines patient access to oncology clinical trials
Trastuzumab biosimilar is a humanized monoclonal antibody for treating metastatic breast cancer
Inducts advanced AI-Powered 24x7 remote patient monitoring system
Subscribe To Our Newsletter & Stay Updated